325 related articles for article (PubMed ID: 28197739)
1. Diagnosis and Treatment of IgG4-Related Disease.
Kamisawa T; Okazaki K
Curr Top Microbiol Immunol; 2017; 401():19-33. PubMed ID: 28197739
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G4-related Disease: A New Systemic Disease Emerging in Japan.
Kamisawa T
JMA J; 2022 Jan; 5(1):23-35. PubMed ID: 35224257
[TBL] [Abstract][Full Text] [Related]
3. IgG4-related disease: a complex under-diagnosed clinical entity.
Yadlapati S; Verheyen E; Efthimiou P
Rheumatol Int; 2018 Feb; 38(2):169-177. PubMed ID: 28681251
[TBL] [Abstract][Full Text] [Related]
4. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of Immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India.
Gupta N; Mathew J; Mohan H; Chowdhury SD; Kurien RT; Christopher DJ; Thangakunam B; Alexander M; Sivadasan A; Tamilarasi V; Valson AT; Gowri M; Kabeerdoss J; Danda D
Rheumatol Int; 2018 Feb; 38(2):203-209. PubMed ID: 28550399
[TBL] [Abstract][Full Text] [Related]
5. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.
Majumder S; Mohapatra S; Lennon RJ; Piovezani Ramos G; Postier N; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Chari ST; Topazian MD; Witzig TE
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1947-1953. PubMed ID: 29526692
[TBL] [Abstract][Full Text] [Related]
6. [Clinical Practice and Examination for IgG4-Related Disease].
Takahashi H; Suzuki C; Yamamoto M
Rinsho Byori; 2015 May; 63(5):590-7. PubMed ID: 26524898
[TBL] [Abstract][Full Text] [Related]
7. An inflammatory condition with different faces: immunoglobulin G4-related disease.
Karim AF; Verdijk RM; Guenoun J; van Hagen PM; van Laar JA
Neth J Med; 2016 Mar; 74(3):110-5. PubMed ID: 27020990
[TBL] [Abstract][Full Text] [Related]
8. The Geoepidemiology and Clinical Aspects of IgG4-Related Disease.
Uchida K; Tanaka T; Gershwin ME; Okazaki K
Semin Liver Dis; 2016 Aug; 36(3):187-99. PubMed ID: 27466790
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
Ebbo M; Grados A; Samson M; Groh M; Loundou A; Rigolet A; Terrier B; Guillaud C; Carra-Dallière C; Renou F; Pozdzik A; Labauge P; Palat S; Berthelot JM; Pennaforte JL; Wynckel A; Lebas C; Le Gouellec N; Quémeneur T; Dahan K; Carbonnel F; Leroux G; Perlat A; Mathian A; Cacoub P; Hachulla E; Costedoat-Chalumeau N; Harlé JR; Schleinitz N
PLoS One; 2017; 12(9):e0183844. PubMed ID: 28915275
[TBL] [Abstract][Full Text] [Related]
10. IgG4-related disease.
Kubo K; Yamamoto K
Int J Rheum Dis; 2016 Aug; 19(8):747-62. PubMed ID: 26259069
[TBL] [Abstract][Full Text] [Related]
11. IgG4-related disease: A relatively new concept for clinicians.
Vasaitis L
Eur J Intern Med; 2016 Jan; 27():1-9. PubMed ID: 26481243
[TBL] [Abstract][Full Text] [Related]
12. Current Concept of IgG4-Related Disease.
Okazaki K; Umehara H
Curr Top Microbiol Immunol; 2017; 401():1-17. PubMed ID: 28091932
[TBL] [Abstract][Full Text] [Related]
13. [IgG4-related disease -Mechanistic insights from both clinical and immunologic understanding of this condition].
Maehara T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):206-212. PubMed ID: 28747608
[TBL] [Abstract][Full Text] [Related]
14. IgG4-related uveitis. A French cohort and literature review.
Stuchfield-Denby E; De Sainte Marie B; Hie M; Hatchuel Y; Gerber A; Bencheikh S; Pugnet G; Groh M; Farhat MM; Urbina D; Ebbo M; Schleinitz N
Semin Arthritis Rheum; 2024 Feb; 64():152278. PubMed ID: 38000318
[TBL] [Abstract][Full Text] [Related]
15. IgG
Ng SH; Tay JS; Lai EL
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34031075
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.
Khosroshahi A; Carruthers MN; Deshpande V; Unizony S; Bloch DB; Stone JH
Medicine (Baltimore); 2012 Jan; 91(1):57-66. PubMed ID: 22210556
[TBL] [Abstract][Full Text] [Related]
17. IgG4-related disease: a systemic condition with characteristic microscopic features.
Detlefsen S
Histol Histopathol; 2013 May; 28(5):565-84. PubMed ID: 23264201
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of leflunomide and glucocorticoids for the maintenance of remission in patients with IgG4-related disease: a retrospective study and literature review.
Wang Y; Li K; Gao D; Luo G; Zhao Y; Wang X; Zhang J; Jin J; Zhao Z; Yang C; Zhu J; Zhang J; Huang F
Intern Med J; 2017 Jun; 47(6):680-689. PubMed ID: 28321964
[TBL] [Abstract][Full Text] [Related]
19. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.
Mattoo H; Mahajan VS; Della-Torre E; Sekigami Y; Carruthers M; Wallace ZS; Deshpande V; Stone JH; Pillai S
J Allergy Clin Immunol; 2014 Sep; 134(3):679-87. PubMed ID: 24815737
[TBL] [Abstract][Full Text] [Related]
20. IgG4-related disease: a clinical perspective.
Maritati F; Peyronel F; Vaglio A
Rheumatology (Oxford); 2020 May; 59(Suppl 3):iii123-iii131. PubMed ID: 32348524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
